ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "a52f7ba7-9635-42a8-89b8-18a80366e173"}, "_deposit": {"id": "22727", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "22727"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00022727", "sets": ["1902"]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1966-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "15", "bibliographicPageStart": "1", "bibliographicVolumeNumber": "29", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "In order to clarify the mechanism of hyperlipemia during pancreatic disorders, investigations on changes of serum lipids, measurements of lipoprotein and number of chylomicra after oral administration of fat (safflower oil or olive oil) and studies on post-heparin lipoprotein lipase were done on patients with chronic pancreatitis and on dogs with experimental pancreatic disorders. The results obtained were as follows. (1) β/α Lipoprotein indices and β-lipoprotein levels were increased in pancreatitis. (2) There was an impaired removal of chylomicra from plasma in pancreatitis. (3) Post-heparin lipoprotein lipase activities in the dogs with pancreatic disorders were significantly lower than those in the normal controls. (4) No inhibitor on lipoprotein lipase activity was detected in plasma in the dogs with pancreatitis. The possible relationships of these phenomena to the mechanism of lipid metabolism in pancreatic disorders have been discussed. It was concluded that the decreased delivery of the lipoprotein lipase into the circulation was one of the possible causes of hyperlipemia in pancreatic disorders.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.29.1.1", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University School of Medicine"}]}, "item_9_relation_43": {"attribute_name": "異版である", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/291/291.html", "subitem_relation_type_select": "URI"}}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_61": {"attribute_name": "ISSN(Online)", "attribute_value_mlt": [{"subitem_source_identifier": "2186-3326", "subitem_source_identifier_type": "ISSN"}]}, "item_9_source_id_7": {"attribute_name": "ISSN(print)", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "FUJITA, AKIO"}], "nameIdentifiers": [{"nameIdentifier": "93879", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "v29n1p1_15.pdf", "filesize": [{"value": "1.9 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1900000.0, "url": {"label": "v29n1p1_15.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/22727/files/v29n1p1_15.pdf"}, "version_id": "136aa9e1-bc4d-4b1c-a729-7e9efd30a698"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Disturbances of Lipid Metabolism in Pancreatic Disorders with Special Reference to Serum Lipoprotein Lipase Activity", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Disturbances of Lipid Metabolism in Pancreatic Disorders with Special Reference to Serum Lipoprotein Lipase Activity"}]}, "item_type_id": "9", "owner": "1", "path": ["1902"], "permalink_uri": "https://doi.org/10.18999/nagjms.29.1.1", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-09-27"}, "publish_date": "2016-09-27", "publish_status": "0", "recid": "22727", "relation": {}, "relation_version_is_last": true, "title": ["Disturbances of Lipid Metabolism in Pancreatic Disorders with Special Reference to Serum Lipoprotein Lipase Activity"], "weko_shared_id": null}
  1. C100 医学部/医学系研究科
  2. C100b 紀要
  3. Nagoya journal of medical science
  4. 29(1)

Disturbances of Lipid Metabolism in Pancreatic Disorders with Special Reference to Serum Lipoprotein Lipase Activity

https://doi.org/10.18999/nagjms.29.1.1
https://doi.org/10.18999/nagjms.29.1.1
a4384fa2-0c08-40fb-ad70-7466e46e7bda
名前 / ファイル ライセンス アクション
v29n1p1_15.pdf v29n1p1_15.pdf (1.9 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2016-09-27
タイトル
タイトル Disturbances of Lipid Metabolism in Pancreatic Disorders with Special Reference to Serum Lipoprotein Lipase Activity
著者 FUJITA, AKIO

× FUJITA, AKIO

WEKO 93879

FUJITA, AKIO

Search repository
抄録
内容記述 In order to clarify the mechanism of hyperlipemia during pancreatic disorders, investigations on changes of serum lipids, measurements of lipoprotein and number of chylomicra after oral administration of fat (safflower oil or olive oil) and studies on post-heparin lipoprotein lipase were done on patients with chronic pancreatitis and on dogs with experimental pancreatic disorders. The results obtained were as follows. (1) β/α Lipoprotein indices and β-lipoprotein levels were increased in pancreatitis. (2) There was an impaired removal of chylomicra from plasma in pancreatitis. (3) Post-heparin lipoprotein lipase activities in the dogs with pancreatic disorders were significantly lower than those in the normal controls. (4) No inhibitor on lipoprotein lipase activity was detected in plasma in the dogs with pancreatitis. The possible relationships of these phenomena to the mechanism of lipid metabolism in pancreatic disorders have been discussed. It was concluded that the decreased delivery of the lipoprotein lipase into the circulation was one of the possible causes of hyperlipemia in pancreatic disorders.
内容記述タイプ Abstract
出版者
出版者 Nagoya University School of Medicine
言語
言語 eng
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
ID登録
ID登録 10.18999/nagjms.29.1.1
ID登録タイプ JaLC
関連情報
関連タイプ isVersionOf
識別子タイプ URI
関連識別子 http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/291/291.html
ISSN(print)
収録物識別子タイプ ISSN
収録物識別子 0027-7622
ISSN(Online)
収録物識別子タイプ ISSN
収録物識別子 2186-3326
書誌情報 Nagoya Journal of Medical Science

巻 29, 号 1, p. 1-15, 発行日 1966-11
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 09:57:30.156192
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3